TerrAscend Says Major U.S. Exchange Listing Is A Matter Of ‘When,’ Not ‘If’

TerrAscend Corp. (TSX:TSND) (OTC:TSNDF) announced Friday that it will hold a special shareholder meeting on August 24 to seek approval for a share consolidation, a move designed to position the company for a potential uplisting to a major U.S. stock exchange.

The announcement makes TerrAscend the latest multi-state operator taking concrete steps toward exchange eligibility as federal cannabis reforms begin reshaping the industry’s capital markets landscape.

The company said the proposed share consolidation is intended to help meet share price requirements established by major U.S. exchanges. Additional details, including the consolidation ratio, will be disclosed in a future shareholder circular.

Another Sign Cannabis Companies Are Preparing For A New Capital Markets Environment

In recent weeks, several major cannabis operators have taken steps widely viewed as preparation for potential exchange listings and broader institutional investor participation.

Verano recently announced a reverse stock split, while Curaleaf previously disclosed a similar move. Earlier this week, Trulieve announced it had secured approval to list on the New York Stock Exchange, becoming the first U.S. cannabis operator to gain access to a major U.S. exchange following medical marijuana rescheduling.

TerrAscend now appears to be following a similar path.

“The regulatory progress that has occurred over the past several months is real and meaningful,” said Executive Chairman Jason Wild.

“We believe uplisting to a major U.S. exchange is no longer a question of if, it is a question of when.”

Years In The Making

According to Wild, the company has been preparing for this possibility for several years.

“We have been positioning the Company for this moment since 2022 when we became an SEC filer,” he said.

The company also disclosed that it has been consulting directly with U.S. stock exchanges as part of its preparation efforts.

The proposed shareholder vote represents one of the final corporate governance steps needed should a listing opportunity emerge.

“This shareholder vote is an important step, and we look forward to sharing additional details ahead of the meeting,” Wild added.

Why Investors Are Paying Attention

For years, U.S. cannabis operators were largely restricted to Canadian exchanges and over-the-counter trading because federal prohibition prevented access to major U.S. markets such as the NYSE and Nasdaq.

That limitation reduced liquidity, restricted institutional ownership, and prevented many large investment funds from investing in the sector.

Recent federal developments have begun changing that equation.

Following the federal government’s decision to move state-licensed medical marijuana products to Schedule III earlier this year, operators have increasingly begun positioning themselves for a future where broader exchange access becomes possible.

For investors, the significance extends beyond individual companies.

Major exchange listings typically bring increased visibility, broader analyst coverage, improved liquidity, and access to a much larger pool of institutional capital.

The result could be a fundamental shift in how cannabis companies raise money, structure transactions, and attract investors.

A Broader Industry Trend

TerrAscend’s move adds to growing evidence that cannabis executives increasingly view exchange access as a realistic near-term opportunity rather than a distant possibility.

The company operates across Pennsylvania, New Jersey, Maryland, Ohio, California, and Canada through a portfolio that includes The Apothecarium, Kind Tree, State Flower, Wana, and several other cannabis brands.

Whether shareholders ultimately approve the share consolidation remains to be seen. But the message from management was clear: TerrAscend believes the industry’s regulatory environment has changed enough to begin preparing for a future on a major U.S. exchange.

As more operators evaluate similar strategies, the question is no longer whether cannabis companies want access to institutional capital. Increasingly, it is how quickly they can position themselves to capture it.

Those questions are likely to be front and center at the Chicago Cannabis Capital Conference on June 15–16, where operators, investors, lenders, and advisors will gather to discuss the evolving relationship between cannabis regulation, capital markets, and exchange access. As the industry enters what could be a new era of institutional participation, the conversation around who is prepared—and who is not—is only beginning.